Articles

Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican experts

José Antonio Magaña Serrano, José Angel Cigarroa López, Adolfo Chávez Mendoza, Juan Betuel Ivey-Miranda, Genaro Hiram Mendoza Zavala, Luis Olmos Domínguez, Sergio Armando Chávez Leal, José Ernesto Pombo Bartelt, Eduardo Heberto Herrera-Garza, Gerardo Mercado Leal, Rodolfo Parra Michel, Luisa Fernanda Aguilera Mora, Patricia Lenny Nuriulu Escobar

Article Type

Review

Published

Heart failure (HF) represents a major healthcare problem, reaching epidemic figures worldwide. This article provides an update on the vulnerable period of HF with reduced ejection fraction (HFrEF) and recommendations are given regarding the management of HF during this phase.

Read more

High-dose amphotericin: yay or nay? A case series and literature review

Kayla R Stover, Taylor E Jordan, Jamie L Wagner, Katie E Barber

Article Type

Review

Published

This case series and literature review characterizes high-dose lipid formulation amphotericin B use and describes the therapeutic effects of high-dose lipid formulations of amphotericin B on patients at one institution and in the literature.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.